Quick Answer
ADMA BIOLOGICS, INC. reported Stockholders Equity of $477.32 million for the year ending 2025.
- ADMA BIOLOGICS, INC. showed an increase of +36.8% in Stockholders Equity from 2024 to 2025.
- This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2012: $9.42 million | Q1 2013: $6.40 million | Q2 2013: $1.73 million | Q3 2013: -$735.8 thousand | Q1 2014: $15.90 million | Q2 2014: $12.30 million | Q3 2014: $9.24 million | Q1 2015: $13.43 million | Q2 2015: $9.52 million | Q3 2015: $4.91 million | Q1 2016: -$3.37 million | Q2 2016: $3.92 million | Q3 2016: -$152.1 thousand | Q1 2017: -$10.76 million | Q2 2017: $27.68 million | Q3 2017: $12.99 million | Q1 2018: $23.03 million | Q2 2018: $51.76 million | Q3 2018: $37.21 million | Q1 2019: $10.04 million | Q2 2019: $46.91 million | Q3 2019: $36.12 million | Q1 2020: $96.34 million | Q2 2020: $76.88 million | Q3 2020: $71.38 million | Q1 2021: $112.50 million | Q2 2021: $111.59 million | Q3 2021: $102.78 million | Q1 2022: $126.93 million | Q2 2022: $114.40 million | Q3 2022: $100.38 million | Q1 2023: $145.66 million | Q2 2023: $146.76 million | Q3 2023: $151.44 million | Q1 2024: $153.71 million | Q2 2024: $188.27 million | Q3 2024: $231.89 million | Q1 2025: $373.42 million | Q2 2025: $398.33 million | Q3 2025: $431.19 million.
- Over the full 16 years of available data (2010 to 2025), ADMA BIOLOGICS, INC.'s Stockholders Equity has grown by 12,255.8%.
- Historical annual values: Fiscal year 2025: $477.32 million | Fiscal year 2024: $349.02 million | Fiscal year 2023: $135.21 million | Fiscal year 2022: $151.97 million | Fiscal year 2021: $141.17 million | Fiscal year 2020: $88.25 million | Fiscal year 2019: $26.19 million | Fiscal year 2018: $19.77 million | Fiscal year 2017: $40.33 million | Fiscal year 2016: -$4.46 million | Fiscal year 2015: $821.0 thousand | Fiscal year 2014: $6.01 million | Fiscal year 2013: $21.57 million | Fiscal year 2012: $9.42 million | Fiscal year 2011: $385.8 thousand | Fiscal year 2010: -$3.93 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: